We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.98B
AUM Growth
+$857M
(+14%)
Cap. Flow
+$784M
Cap. Flow
% of AUM
11.24%
Top 10 Holdings %
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qorvo
QRVO
|
+$153M |
| 2 |
ASML
ASML
|
+$117M |
| 3 |
Revolution Medicines
RVMD
|
+$58.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$49.6M |
| 5 |
Intuitive Surgical
ISRG
|
+$48.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$132M |
| 2 |
Qualcomm
QCOM
|
+$77.3M |
| 3 |
Abbott
ABT
|
+$69.2M |
| 4 |
Booking.com
BKNG
|
+$67.7M |
| 5 |
KLA
KLAC
|
+$63.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.18% |
| 2 | Technology | 29.45% |
| 3 | Communication Services | 6.73% |
| 4 | Industrials | 6.43% |
| 5 | Financials | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMYS
201
DELISTED
dMY Technology Group, Inc. VI
DMYS
| $9.82M | 0.14% |
+1,000,000
| New | +$9.91M |
|
|
FRGE
202
DELISTED
Forge Global Holdings
FRGE
| $9.73M | 0.14% |
65,919
+50,000
| +314% | +$7.44M |
|
|
EPIX
203
DELISTED
ESSA Pharma
EPIX
| $9.72M | 0.14% |
684,247
+507,239
| +287% | +$5.65M |
|
204
Acadia Pharmaceuticals
ACAD
$4.36B
| $9.71M | 0.14% |
416,200
-172,659
| -29% | -$3.47M |
|
205
Petco
WOOF
$822M
| $9.67M | 0.14% |
488,790
+121,237
| +33% | +$2.65M |
|
206
AbCellera Biologics
ABCL
$1.78B
| $9.59M | 0.14% |
670,639
+273,823
| +69% | +$4.16M |
|
|
PVLA
207
Palvella Therapeutics
PVLA
$2.01B
| $9.31M | 0.13% |
+30,796
| New | +$9.86M |
|
208
Visa
V
$682B
| $9.28M | 0.13% |
42,800
-11,000
| -20% | -$2.36M |
|
209
Biogen
BIIB
$29.6B
| $9.06M | 0.13% |
37,781
-14,637
| -28% | -$3.76M |
|
|
CNTA
210
DELISTED
Centessa Pharmaceuticals
CNTA
| $9.02M | 0.13% |
801,136
-81,677
| -9% | -$1.1M |
|
211
Northrop Grumman
NOC
$77.3B
| $8.94M | 0.13% |
+23,097
| New | +$8.6M |
|
212
BioAtla
BCAB
$5.53M
| $8.76M | 0.13% |
8,923
+5,909
| +196% | +$7.56M |
|
|
INFN
213
DELISTED
Infinera Corporation Common Stock
INFN
| $8.73M | 0.13% |
+910,665
| New | +$7.72M |
|
214
T-Mobile US
TMUS
$189B
| $8.69M | 0.12% |
74,953
-273,624
| -78% | -$32.2M |
|
|
PDCO
215
DELISTED
Patterson Companies, Inc.
PDCO
| $8.58M | 0.12% |
+292,360
| New | +$9.15M |
|
216
Revvity
RVTY
$12.8B
| $8.53M | 0.12% |
+42,400
| New | +$7.66M |
|
|
XLNX
217
DELISTED
Xilinx Inc
XLNX
| $8.52M | 0.12% |
40,180
+5,220
| +15% | +$1.03M |
|
|
VNE
218
DELISTED
Veoneer, Inc.
VNE
| $8.43M | 0.12% |
+237,500
| New | +$8.4M |
|
219
Prestige Consumer Healthcare
PBH
$2.47B
| $8.37M | 0.12% |
138,038
+71,550
| +108% | +$4.25M |
|
|
OLPX
220
DELISTED
Olaplex Holdings
OLPX
| $8.18M | 0.12% |
280,792
+47,457
| +20% | +$1.26M |
|
|
KRA
221
DELISTED
Kraton Corporation
KRA
| $8.05M | 0.12% |
+173,751
| New | +$7.97M |
|
|
NVRO
222
DELISTED
NEVRO CORP.
NVRO
| $8.03M | 0.12% |
99,005
-64,837
| -40% | -$6.5M |
|
|
SNRH
223
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
| $7.98M | 0.11% |
818,975
| – | – |
|
|
ATH
224
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $7.92M | 0.11% |
95,080
+4,220
| +5% | +$346K |
|
|
FLOW
225
DELISTED
SPX FLOW, Inc.
FLOW
| $7.91M | 0.11% |
+91,490
| New | +$7.36M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.
- Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
- Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
- Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
- Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
- Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
- Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
- Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.
Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.